V

Viking Global

Global investment firm; manages public/private equity.

Overview

Viking Global Investors is a global investment firm managing over $48 billion in capital across public and private markets. It uses fundamental analysis and long/short strategies, taking long positions in undervalued companies and short positions in overvalued ones, across public equity, private equity, credit, and structured capital. The firm serves institutional investors, high-net-worth individuals, and qualified investors, aiming to generate high risk-adjusted returns. Fees come from management and performance-based charges. The main difference from competitors lies in its emphasis on fundamental, long/short investing across both public and private markets and its broad, globally distributed investment approach.

Work here?Claim your company

About Viking Global

Simplify's Rating
Why Viking Global is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Quantitative FinanceFinancial Services

Company Size

51-200

Company Stage

N/A

Total Funding

$19B

Headquarters

Greenwich, Connecticut

Founded

1999

Get referred to Viking Global

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pearl Health reached profitability in 2025, and Viking joined its $110 million round.
  • Viking's r-pac investment expands fee-generating structured capital alongside public equity.
  • Samsung Electronics lifted Viking's second-quarter results after AI supply-chain exposure in 2026.

What critics are saying

  • Viking's flagship fund gained 2.6% in H1 2026, lagging Coatue and Lone Pine.
  • Delaware Chancery froze 32.1 million Talkdesk shares after Viking consent-rights claims.
  • If AI rallies persist, 2027 inflows shift toward faster-moving rivals and pressure fees.

What makes Viking Global unique

  • Andreas Halvorsen still anchors Viking's valuation discipline, avoiding momentum-chasing in AI froth.
  • Viking Structured Capital led r-pac's $175 million deal on June 15, 2026.
  • Viking backed TriGemX Bio and GT Medical in 2026, spanning biotech and devices.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$19B

Above

Industry Average

Funded Over

0 Rounds

Benefits

  • Health Insurance
  • Dental Insurance
  • Performance Bonus
  • Meal Benefits
  • Hybrid Work Options

Company News

Business Wire
Oct 13th, 2026
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, toda...

FinSMEs
Oct 1st, 2026
TriGemX Bio raises $94M to advance phase 3 migraine treatment trials

TriGemX Bio, a New York City-based biotechnology company focused on migraine treatment, raised $94 million in funding. The round was co-led by The Column Group, TCGX, and Viking Global Investors, with participation from additional investors. The company will use the funds to advance clinical development of elismetrep, its lead program. Elismetrep is a novel, oral TRPM8 channel blocker currently in Phase 3 trials for acute migraine treatment. Led by chief executive officer Jeff Goater, TriGemX Bio develops medicines by leveraging insights into neural signalling pathways. The platform focuses on targeting migraine-relevant neural structures such as the trigeminal ganglion to deliver therapies for affected patients. The company was formerly known as Kallyope.

SGB Media
Sep 20th, 2026
Ecovative Raises Over $30 Million

Ecovative Design LLC, the eco-friendly materials company based in Green Island, NY, announced it initially closed on a Series E round of over $30 million.

Business Wire
Sep 12th, 2026
DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today anno...

PR Newswire
Jul 8th, 2026
Pearl Health raises $110M to expand AI platform for Medicare care management

Pearl Health has raised $110 million to expand its AI platform for managing Medicare patient care. The funding comprises a $50 million equity round led by Andreessen Horowitz, with participation from Viking Global Investors, AlleyCorp and Ulysses Capital, plus a $60 million debt facility from Trinity Capital. The company reached profitability in 2025 and projects $500 million in gross healthcare system savings whilst tripling its patient base from 2024 through end-2026. Pearl's platform helps providers predict risk and automate workflows before issues become emergencies. Pearl supports over 10,000 providers across 40 states, caring for more than 250,000 Medicare beneficiaries. It manages approximately $3.6 billion in annualised medical spend, up from $2.4 billion the previous year.

Recently Posted Jobs

Sign up to get curated job recommendations

Viking Global is Hiring for 5 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs